These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36334453)

  • 1. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens.
    Deng C; Yan H; Wang J; Liu K; Liu BS; Shi YM
    Eur J Med Chem; 2022 Dec; 244():114888. PubMed ID: 36334453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antibacterial Activity of 1,2,3-triazole- and 1,2,4-Triazole-containing Hybrids against
    Li J; Zhang J
    Curr Top Med Chem; 2022; 22(1):41-63. PubMed ID: 34766892
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
    Zhang B
    Eur J Med Chem; 2019 Apr; 168():357-372. PubMed ID: 30826511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens.
    Gao J; Hou H; Gao F
    Eur J Med Chem; 2023 Feb; 247():115026. PubMed ID: 36577217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
    Xu Z
    Eur J Med Chem; 2020 Nov; 206():112686. PubMed ID: 32795773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity study of 1,2,4-triazole derivatives.
    Gao F; Wang T; Xiao J; Huang G
    Eur J Med Chem; 2019 Jul; 173():274-281. PubMed ID: 31009913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents.
    Zhang J; Wang S; Ba Y; Xu Z
    Eur J Med Chem; 2019 Jul; 174():1-8. PubMed ID: 31015103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triazole-containing hybrids with anti-
    Tan Z; Deng J; Ye Q; Zhang Z
    Future Med Chem; 2021 Apr; 13(7):643-662. PubMed ID: 33619989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,2,4-Triazole hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus.
    Ge X; Xu Z
    Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000223. PubMed ID: 32985011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in quinolone hybrids with potential antibacterial activity against drug-resistant bacteria.
    Jun W; Yumin S; Heng Y
    Future Med Chem; 2023 Mar; 15(6):555-578. PubMed ID: 37102377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic potential of indole hybrids, dimers, and trimers against drug-resistant ESKAPE pathogens.
    Qiongxian Y; Jun D; Zhenfeng Z; Tongyou L; Zhicong T; Zhenyou T
    Arch Pharm (Weinheim); 2024 Jun; ():e2400295. PubMed ID: 38924571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids.
    Gao Y; Na LX; Xu Z; Zhang S; Wang AP; Lü K; Guo HY; Liu ML
    Chem Biodivers; 2018 Oct; 15(10):e1800261. PubMed ID: 29987907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the application of 1,2,4-triazole-containing hybrids as anti-tuberculosis agents.
    Cao Y; Lu H
    Future Med Chem; 2021 Dec; 13(23):2107-2124. PubMed ID: 34698509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens.
    Behroozian S; Svensson SL; Davies J
    mBio; 2016 Jan; 7(1):e01842-15. PubMed ID: 26814180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-breast cancer therapeutic potential of 1,2,3-triazole-containing hybrids.
    Song J; Zhang S; Zhang B; Ma J
    Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300641. PubMed ID: 38110853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic potential against cancers: A mini-review.
    Zhao S; Liu J; Lv Z; Zhang G; Xu Z
    Eur J Med Chem; 2023 May; 251():115254. PubMed ID: 36893627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in 1,2,3- and 1,2,4-triazole hybrids as antimicrobials and their SAR: A critical review.
    Tian G; Song Q; Liu Z; Guo J; Cao S; Long S
    Eur J Med Chem; 2023 Nov; 259():115603. PubMed ID: 37478558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current scenario of tetrazole hybrids for antibacterial activity.
    Gao F; Xiao J; Huang G
    Eur J Med Chem; 2019 Dec; 184():111744. PubMed ID: 31605865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel antibacterial drugs to combat multiple resistant organisms.
    Bassetti M; Righi E
    Langenbecks Arch Surg; 2015 Feb; 400(2):153-65. PubMed ID: 25667169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.